AzTrials
AzTrials

Chronic Obstructive Pulmonary DiseaseRECOPDNCT01786928

The Role of Resistance Exercise in Chronic Obstructive Pulmonary Disease Exacerbation

A study testing Resistance training in people with Chronic Obstructive Pulmonary Disease, run by University of Sao Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether resistance exercise are effective in combating the decline in muscle strength during an exacerbation of Chronic Obstructive Pulmonary Disease (COPD). Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Chronic Obstructive Pulmonary Disease
What is being tested?
Resistance training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteBrazil
Study dates
Apr 2009to Oct 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients hospitalized for exacerbation of COPD

Who cannot join

  • patients presenting change in mental status (confusion, lethargy or coma)
  • persistence or worsening in hypoxemia (PaO2<40mmHg) and/or respiratory acidosis (pH<7.25) despite oxygen supplementation or use of non-invasive ventilation
  • hemodynamic instability requiring vasoactive drugs
  • patients transferred to ICU
  • hospitalization lower than 5 days
  • diseases that prevented the exercises

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • University Hospital of sao paulo

    São Paulo, São Paulo, 05508-000

Other trials in Brazil

About this study

Official title: Impact of Resistance Training During Hospitalization in COPD Patients: a Randomized and Controlled Trial

The purpose of this study is to determine whether resistance exercise are effective in combating the decline in muscle strength during an exacerbation of Chronic Obstructive Pulmonary Disease (COPD).

Read the detailed description

Acute exacerbations are common in patients with COPD and cause specific signs and symptoms, such as increased dyspnea, productive cough with altered sputum, and fever. With disease progression, exacerbations are frequent and have a negative impact on health related quality of life and pulmonary function as well as increase mortality. More severe exacerbations require hospitalization resulting in enormous health expenditures, severely reducing daily life activities and declining peripheral muscle strength that can be only partially reversed after 3 months. Despite many features have been pointed out as responsible for the decrease in muscle strength during hospitalization, physical inactivity seems the most important.

Resistance training is an interesting therapeutic option to prevent and/or reverse muscular dysfunction due to immobilised in healthy subjects and stable COPD patients because induces hypertrophy of type II fibers, increases muscle strength and exercise tolerance. In addition, provokes lower dyspnea perception during effort compared with other exercise training. Despite these benefits for stable COPD, the impact of a resistance exercise program during hospitalization remains poorly known.

Keywords
chronic obstructive pulmonary disease, exacerbation, resistance training, muscle force
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance trainingOther

    Resistance training group received training program for upper (shoulder flexion and abduction and biceps) and lower limbs (knee extension and flexion and hip flexion). Daily exercise for every muscle was performed with free weights at 80% of an maximal repetition test and a 4 minutes rest was allowed between each step.

Study groups in NCT01786928
Study groupRoleWhat they receive
resistance trainingExperimentalresistance training of the upper and lower limbs, two series of 80% of repetition maximum test
Receives: Other: Resistance training
ControlNo interventionTraditional Respiratory Therapy for bronchial hygiene

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The benefits of resistance training during exacerbation of COPD on peripheral muscle strength during hospitalization

    The metric used to evaluate the strength gain is given in kilogram (absolute value) and percentage relative to that obtained on the second hospital day

    Measured: Will be evaluated on the second day of hospitalization, the day of hospital discharge (this time interval must be longer than five days)

Secondary outcomes (1)
  1. The benefits of resistance training during exacerbation of COPD on physical activity in daily life

    The metric used to evaluate the changes will be given in minutes and percentage of total time

    Measured: Will be evaluated in the third and fifth day of hospitalization and thirty days after discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2013 (estimated)
  2. Study startApr 2009
  3. Primary completionDec 2009
  4. Study completionOct 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01786928
Sponsor's protocol ID
PTR-001-RCB
Acronym
RECOPD
Status last verified
Feb 2013
First submitted
10 Jan 2012
Last updated
8 Feb 2013
Results posted
No
Data monitoring committee
No

Publications

  • Borges RC, Carvalho CR. Impact of resistance training in chronic obstructive pulmonary disease patients during periods of acute exacerbation. Arch Phys Med Rehabil. 2014 Sep;95(9):1638-45. doi: 10.1016/j.apmr.2014.05.007. Epub 2014 May 28.

    PubMed 24879965

Questions about this trial

What is this clinical trial studying?

A study testing Resistance training in people with Chronic Obstructive Pulmonary Disease, run by University of Sao Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The benefits of resistance training during exacerbation of COPD on peripheral muscle strength during hospitalization (time frame: Will be evaluated on the second day of hospitalization, the day of hospital discharge (this time interval must be longer than five days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01786928, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in